期刊文献+

一氧化氮介导的肿瘤治疗研究进展 被引量:13

Research Advances on Tumor Therapy via Nitric Oxide
下载PDF
导出
摘要 一氧化氮(nitricoxide,NO)是一种半衰期短的多效分子,参与机体内的多种生理和病理反应。它作为重要的生物介质在肿瘤发生、发展和死亡中的作用已成为肿瘤研究及治疗的热点。研究发现NO具有促瘤或抗瘤的作用,这种双重作用取决于NO生成的浓度、时间和效应部位。持续低浓度的NO可以促进肿瘤的生长;高浓度NO则通过产生细胞毒性,诱导细胞凋亡而抗瘤。NO的这种浓度依赖性机制是目前NO介导的肿瘤治疗的理论基础,这些治疗方法可分为以下几类:包括化疗药物、中药、一氧化氮合酶的诱导剂和抑制剂在内的药物治疗;放疗和光动力学治疗;基因水平治疗等。本文从NO生成的浓度、时间和效应部位三个方面阐述NO和肿瘤的关系及其作用机制,并综述NO介导的各种肿瘤治疗方法的研究进展。 Nitric oxide (NO) is a short- lived pleiotropic molecule invo lv ed in many physiological and pathological processes in the organism. As an impor tant biologic mediator, nitric oxide has been focused in tumor study and therapy for its function in the process of tumor genesis, progression,and death. It is documented that nitric oxide plays a dual role:induction or suppression of tumor igenesis, which is dependent on different conditions, such as the concentration, time,and position of NO products. Tumor growth can be promoted by continuous lo w NO concentration, while cytotoxicity and apoptosis to tumor cells can be induc ed by quite high NO concentration. Currently, the concentration- dependent prin ciple is the theoretical basis of tumor therapy mediated by NO. These tumor ther apies can be classified into several types: firstly, drug treatments including c hemotherapy, nitric oxide synthase inducer and inhibitor, together with related research from Chinese traditional medicine; secondly, radiotherapy and photodyna mic therapy; thirdly, genic level therapy; and so on. Thus, the paper states the relationship and mechanism between NO and tumor, and summarizes research advanc es on tumor therapy via nitric oxide.
出处 《癌症》 SCIE CAS CSCD 北大核心 2004年第4期476-479,共4页 Chinese Journal of Cancer
基金 国家自然基金(39880031) 武汉市青年科技晨光计划(20005004023)
关键词 一氧化氮 肿瘤 治疗 NO 效应部位 Nitric Oxide Tumor Therapy
  • 相关文献

参考文献25

  • 1Jenkins DC,Charles IG,Thomsen LL,et al. Roles of nitric oxide in tumor growth [J]. Proc Natl Acad Sci U S A,1995,92(10):4392- 4396.
  • 2Kiechle FL,Zhang X. Apoptosis:biochemical aspects and clinical implications [J]. Clin Chim Acta,2002,326(1- 2):27- 45.
  • 3Moncada S,Palmer RM,Higgs EA. Nitric oxide:physiology, pathophysiology, and pharmacology [J].Pharmacol Rev,1991,43(2):109- 142.
  • 4Soliman MK,Mazzio E,Soliman KF. Levodopa modulating effects of inducible nitric oxide synthase and reactive oxygen species in glioma cells [J]. Life Sci,2002,72(2):185- 198.
  • 5白莲花,于春,顾芳,鲍秋莉,李娟,陈乃玲.新城鸡瘟病毒激活的鼠巨噬细胞对肝癌细胞(H_(22))杀伤作用的探讨[J].癌症,1998,17(4):262-264. 被引量:5
  • 6Jurasz P,Sawicki G,Duszyk M,et al. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation:regulation by nitric oxide [J]. Cancer Res,2001,61(1):376- 382.
  • 7Lala PK,Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression [J]. Lancet Oncol,2001,2(3):149- 156.
  • 8Maurer TS,Fung HL. Evaluation of nitric oxide synthase activity and inhibition kinetics by chemiluminescence [J]. Nitric Oxide,2000,4(4):372- 378.
  • 9Zaks-Zilberman M,Zaks TZ,Vogel SN. Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines [J]. Cytokine,2001,15(3):156- 165.
  • 10Loibl S,von Minckwitz G,Weber S, et al. Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy [J]. Cancer,2002,15,95(6):1191- 1198.

二级参考文献62

共引文献20

同被引文献172

引证文献13

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部